Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Self-Defense Training in Women With Trauma: Complete Statistical AnalysisIndependent statistical analysis of Self-Defense Training in Women With Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01380379).
- Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids: Complete Statistical AnalysisIndependent statistical analysis of Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06560918).
- Self-Management in Parents of Technology-Dependent Children: Complete Statistical AnalysisIndependent statistical analysis of Self-Management in Parents of Technology-Dependent Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04105244).
- Self-management Intervention for Children With Chronic Medical Complexity: Pilot Feasibility Trial: Complete Statistical AnalysisIndependent statistical analysis of Self-management Intervention for Children With Chronic Medical Complexity: Pilot Feasibility Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Self-Management Intervention: Considering Needs & Preferences of Dementia Caregivers (Caregiver Career Study): Complete Statistical AnalysisIndependent statistical analysis of Self-Management Intervention: Considering Needs & Preferences of Dementia Caregivers (Caregiver Career Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Self-Management of Chronic Depressive Symptoms in Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Self-Management of Chronic Depressive Symptoms in Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02953990).
- Self-sampling for Human Papillomavirus (HPV) Among Patients Receiving Colposcopy: Complete Statistical AnalysisIndependent statistical analysis of Self-sampling for Human Papillomavirus (HPV) Among Patients Receiving Colposcopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04585243).
- Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet: Complete Statistical AnalysisIndependent statistical analysis of Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Self-System Therapy for Older Adults With Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Self-System Therapy for Older Adults With Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04057196).
- Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SELPHIndependent statistical analysis of Intervention to Improve Expression of End of Life Preferences for Homeless Persons: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma: Complete Statistical AnalysisIndependent statistical analysis of Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine: Complete Statistical AnalysisIndependent statistical analysis of Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SELUTION4ISRIndependent statistical analysis of SELUTION SLR™ 014 In-stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04280029).
- Semaglutide for Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Semaglutide for Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05520775).
- SEMMAPIndependent statistical analysis of NCCL Direct Composite Restoration Performance With Self-Etch and Multimode Adhesives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02698371).
- SENECAIndependent statistical analysis of Stem Cell Injection in Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02509156).
- SENIORIndependent statistical analysis of Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications: primary endpoint results, effect estimate…
- Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210986).
- SENSE-HFIndependent statistical analysis of Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sensoril(Ashwaganhda)for Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Sensoril(Ashwaganhda)for Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00761761).
- Sensory Effects of Rapidly-Changing Magnetic Fields: Complete Statistical AnalysisIndependent statistical analysis of Sensory Effects of Rapidly-Changing Magnetic Fields: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01632800).
- Sensory Stimulation During CIMT: Complete Statistical AnalysisIndependent statistical analysis of Sensory Stimulation During CIMT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03558230).
- SensoryFLOIndependent statistical analysis of Effects of Acute Intermittent Hypoxia on Sensory Function in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SentimarkIndependent statistical analysis of Magnetic Seed Localisation of Breast Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02635737).
- Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.: Complete Statistical AnalysisIndependent statistical analysis of Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.: primary endpoint results, effect…
- SENTIOIndependent statistical analysis of Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SEPCELLIndependent statistical analysis of Cx611-0204 SEPCELL Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03158727).
- Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sequential and Hybrid Therapies for H Pylori Infection: Complete Statistical AnalysisIndependent statistical analysis of Sequential and Hybrid Therapies for H Pylori Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01085786).
- Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00856180).
- Sequential Vaccinations in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Sequential Vaccinations in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00060528).
- SequoiaIndependent statistical analysis of Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SEQUOIA-HCMIndependent statistical analysis of Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM: primary endpoint results, effect estimate with confidence interval, sample-size…
- SERAPHIN OLIndependent statistical analysis of Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size…
- SERCA-LVADIndependent statistical analysis of Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SERENA-2Independent statistical analysis of A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative…
- SERENEIndependent statistical analysis of Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy: primary endpoint results, effect…
- SERENEIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis: primary endpoint results, effect…
- SERENITY IIIndependent statistical analysis of Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04276883).
- SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII): Complete Statistical AnalysisIndependent statistical analysis of SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00455923).
- SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery: Complete Statistical AnalysisIndependent statistical analysis of SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Serial Movement Assessment in Collegiate Athletes Who Perform Injury Prevention Training: Complete Statistical AnalysisIndependent statistical analysis of Serial Movement Assessment in Collegiate Athletes Who Perform Injury Prevention Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC): Complete Statistical AnalysisIndependent statistical analysis of Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04508725).